Left ventricular assist device driveline infections: Recent advances and future goals

Journal of Thoracic Disease

Volumn 7, Issue 12, 2015, Pages 2151-2157

  Leuck, Anne Marie ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Biofilm; Device related infection; Driveline infections (DLIs); Left ventricular assist devices (LVADs)

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; DRIVELINE INFECTION; HEART FAILURE; HUMAN; IMPLANTATION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; REVIEW; TOPICAL TREATMENT; VENTRICULAR ASSIST DEVICE; WOUND DRESSING;

EID: 84954182656     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.11.06     Document Type: Review

References (42)

1. Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin 2011;29:515-27.
2. Akhter SA, Badami A, Murray M, et al. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis. Ann Thorac Surg 2015;100:884-9.
3. Wickline SA, Fischer KC. Can infections be imaged in implanted devices? ASAIO J 2000;46:S80-1.
4. Nienaber JJ, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 2013;57:1438-48.
5. Trachtenberg BH, Cordero-Reyes A, Elias B, et al. A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management. Methodist Debakey Cardiovasc J 2015;11:28-32.
6. Goldstein DJ, Naftel D, Holman W, et al. Continuousflow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant 2012;31:1151-7.
7. Koval CE, Rakita R; AST Infectious Diseases Community of Practice. Ventricular assist device related infections and solid organ transplantation. Am J Transplant 2013;13 Suppl 4:348-54.
8. Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011;30:375-84.
9. Lushaj EB, Badami A, Osaki S, et al. Impact of age on outcomes following continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg 2015;20:743-8.
10. Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007;84:515-20.
11. Levy DT, Minamoto GY, Da Silva R, et al. Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections. ASAIO J 2015;61:e5-10.
12. Dell'Aquila AM, Mastrobuoni S, Alles S, et al. Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device. Ann Thorac Surg 2016;101:87-94.
13. Fujino T, Higo T, Tanoue Y, et al. FDG-PET/CT for driveline infection in a patient with implantable left ventricular assist device. Eur Heart J Cardiovasc Imaging 2016;17:23.
14. Nienaber J, Wilhelm MP, Sohail MR. Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti Infect Ther 2013;11:201-10.
15. Hamdan R, Ali F, Saab M. Complicated Left Ventricular Assist Device Infection Treated With Pump Exchange and Left Ventricular Apical Resection. Artif Organs 2015;39:981-2.
16. Koval CE, Thuita L, Moazami N, et al. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients. J Heart Lung Transplant 2014;33:1164-72.
17. Kornberger A, Walter V, Khalil M, et al. Suspected involvement of EPTFE membrane in sterile intrathoracic abscess and pericardial empyema in a multi-allergic LVAD recipient: a case report. J Cardiothorac Surg 2015;10:99.
18. Toba FA, Akashi H, Arrecubieta C, et al. Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections. J Thorac Cardiovasc Surg 2011;141:1259-64.
19. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol 2010;8:623-33.
20. Haglund NA, Davis ME, Tricarico NM, et al. Readmissions After Continuous Flow Left Ventricular Assist Device Implantation: Differences Observed Between Two Contemporary Device Types. ASAIO J 2015;61:410-6.
21. Coiffier G, Albert JD, Arvieux C, et al. Optimizing combination rifampin therapy for staphylococcal osteoarticular infections. Joint Bone Spine 2013;80:11-7.
22. Tang HJ, Chen CC, Cheng KC, et al. In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2013;57:5717-20.
23. Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev 2010;23:14-34.
24. Lopilato AC, Doligalski CT, Caldeira C. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients. Artif Organs 2015;39:939-44.
25. Trachtenberg BH, Cordero-Reyes AM, Aldeiri M, et al. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail 2015;21:119-25.
26. Jennings DL, Chopra A, Chambers R, et al. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Artif Organs 2014;38:875-9.
27. Moazami N, Milano CA, John R, et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg 2013;95:500-5.
28. Anand J, Singh SK, Hernández R, et al. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg 2015;149:267-75, 278.e1.
29. Levy DT, Guo Y, Simkins J, et al. Left ventricular assist device exchange for persistent infection: a case series and review of the literature. Transpl Infect Dis 2014;16:453-60.
30. Bhatia N, Voelkel AJ, Hussain Z, et al. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation. Thorac Cardiovasc Surg 2015;63:675-83.
31. Swartz TH, Huprikar S, Labombardi V, et al. Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia. Transpl Infect Dis 2013;15:E177-81.
32. Evans AC, Wright GA, McCandless SP, et al. Ultraviolet Radiation Affects Thoratec HeartMate II Driveline Mechanical Properties: A Pilot Experiment. ASAIO J 2015;61:731-3.
33. John R, Aaronson KD, Pae WE, et al. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device. J Heart Lung Transplant 2014;33:1066-73.
34. Fleissner F, Avsar M, Malehsa D, et al. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices. Artif Organs 2013;37:102-7.
35. Entwistle J. Intraoperative positioning to prevent driveline insulation from acting as a conduit for left ventricular assist device pocket infection. J Thorac Cardiovasc Surg 2014;148:2437.
36. Pinninti M, Thohan V, Sulemanjee NZ. Driveline insulation as a conduit for left ventricular assist device pocket infection. J Thorac Cardiovasc Surg 2014;148:e135-6.
37. Dean D, Kallel F, Ewald GA, et al. Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry. J Heart Lung Transplant 2015;34:781-9.
38. Rubinfeld G, Levine JP, Reyentovich A, et al. Management of Rapidly Ascending Driveline Tunnel Infection. J Card Surg 2015;30:853-5.
39. Imamura T, Kinugawa K, Nitta D, et al. Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during longterm left ventricular assist device support. J Artif Organs 2015;18:120-7.
40. Iseler J, Hadzic KG. Developing a kit and video to standardize changes of left ventricular assist device dressings. Prog Transplant 2015;25:224-9.
41. Wus L, Manning M, Entwistle JW 3rd. Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients. Heart Lung 2015;44:225-9.
42. Menon AK, Baranski SK, Unterkofler J, et al. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation. Thorac Cardiovasc Surg 2015;63:670-4.